Decheng Capital is an institutional investor (Conventional VCs) founded in 2011 and headquartered in Menlo Park, United States. 5 Billion of Capital Building Legendary Companies Decheng Capital is an investment firm that provides capital and strategic support to early-stage life science companies with revolutionary technologies and growth stage healthcare companies with strong market presence. Founded in 2012, Decheng continues to capitalize on a historic opportunity in the rapid growth of healthcare industry as well as breakthroughs in life science research. 5 billion AUM and the support from some of the most prestigious limited partners in the world, Decheng is poised to create value for our investors and entrepreneur partners. Venture capital firm focused on life science and technology sectors. Assets Under Management (AUM): Asset Under Management Over $2.5 billion.

Stage

Not disclosed

HQ

Shanghai, china

Founded

2011

Website

https://decheng.com

LinkedIn

https://linkedin.com/company/decheng-capital-

Preparing to pitch Decheng Capital?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.